02.03.25
‘Reinvigorate the therapeutics pipeline’ urges 100 Days Mission report
Prioritizing early-stage R&D to advance therapeutics for high-risk viral families is one of three key action steps for 2025.
08.30.24
Public health experts put out call for collaboration in antiviral therapeutics development coalition
02.08.24
READDI and SAS get ahead of the next pandemic with AI and machine-learning fueled drug discovery
05.20.22